The open index of psychedelic research

Legislative pathways as dissemination strategies: A protocol for examining psychedelics reform speed, content, and cross-state diffusion

Wang Z, Daily J, Adams DR

Understanding treatment expectations toward emerging therapies in veterinary medicine: the role of knowledge, attitudes, and beliefs toward psychedelic-assisted interventions.

Suárez-Fernández Y, Hernández-Álvarez E, Borkel LF +3

Permeably enclosed raw matrices direct analysis in real time mass spectrometry (PERM-DART-MS): a novel solution for the analysis of untreated samples.

Narcelli Pestana de Aguiar A, Gutiérrez Beleño LM, de Aquino Neto FR +1

Incidence, prevalence and determinants of substance-induced mental disorders in British Columbia, 2022-2023: a population-based study.

Mohebbian M, Schütz CG, Kassam R +2

Transcriptional benchmarking of human monocyte-derived microglia-like cells and iPSC-derived microglia reveals distinct immune-alert and homeostatic programmes

Quek H, Etebar F, Cuní-López C +5

[Illicit use of classic psychedelics and suicidality: A systematic literature review].

Pereira de Oliveira AB, Hein M

Acute cardiovascular complications of sympathomimetic recreational drug use.

Gresnigt FMJ

Analgesic Effects of Low Dose Ketamine in Patients Undergoing Spine Fusion Surgery.

Singh V, Dar BA, Sehar Z +3

CB1R-dependent mitochondrial biogenesis may contribute to the antidepressant effects of esketamine in a chronic variable stress male mouse model.

Zhao W, Zhao X, Zhang Y +7

A scoping review: ketamine or esketamine when used to assist psychotherapy or in combination with psychotherapy for the management of depression in adults.

Swainson J, Grewal P, Polard S +9

Response to "Comment on The effect of perioperative ketamine and esketamine administration on postoperative nausea and vomiting in patients undergoing general anesthesia: a systematic review and meta-analysis".

Seo KH

Reading the Signal: What Psychedelic Trials in Depression Still Can't Tell Us.

Brown SM, Modesto Lowe V, Chaplin M

Reply to "Reading the Signal: What Psychedelic Trials in Depression Still Can't Tell Us".

Horato N, Dalvi-Garcia F, Dutra PEP +1

Classic Psychedelics for Treating Chronic Pain: Mechanism and Clinical Translation.

Chen H, Ke B, Jiang R

Current Approaches to Sedation and Anesthesia in Endoscopy Units: Integrating Pharmacology, Monitoring, and Patient Safety.

Sahin F, Erdem AF, Preckel B

Ketamine preserves perineuronal nets in chronic stressed mice brain through the inhibition of microglia activation.

Yang J, Huang T, Wang M +6

The functional role of ERK activity in esketamine's antidepressant effects.

Zhang P, Wu M, Zhang K +5

Spectral power, but not phase connectivity, decodes the subanaesthetic ketamine state from surface EEG: the role of between-subject transferability

Schätzle H, von Wegner F

Comparative Assessment of Oral Premedication Regimens in Pediatric Ambulatory Surgery

Conceptual analysis of mechanisms and methods in psychedelic clinical trial design: a narrative review.

Krsak M, Sparrow D, Rosner B +2

Perfusion Index and Hemodynamic Responses During Propofol Induction with Fentanyl or Ketamine-Lidocaine Adjuncts: A Prospective Randomized Pilot Clinical Study.

Klibus M, Bhavsar RP, Jagodzinska Peskova J +4

Elunetirom, a brain-targeted TRβ prodrug, promotes neuronal plasticity and mitochondrial biogenesis-related signaling in primary neuronal cultures

Harris JR, Baccei J, Stratton W +4

Changing Patterns of Recent Substance Use in Emerging Adulthood and Their Associations With Cognitive Functions and Mental Health.

Eggenberger L, Janousch C, Johnson-Ferguson L +6

Time-dependent effects of rapid-acting antidepressants in iPSC-derived neurons from treatment-resistant depression and healthy volunteers.

Johnston JN, Jones GH, Peng S +12